New Risk • Mar 25
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 1.2% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Payout ratio: 94% Cash payout ratio: 145% Earnings are forecast to decline by an average of 1.2% per year for the foreseeable future. Price Target Changed • Mar 25
Price target decreased by 8.1% to JP¥4,420 Down from JP¥4,810, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of JP¥4,575. Stock is up 5.5% over the past year. The company is forecast to post earnings per share of JP¥240 for next year compared to JP¥235 last year. Announcement • Mar 05
Noevir Holdings Co., Ltd. to Report First Half, 2026 Results on May 13, 2026 Noevir Holdings Co., Ltd. announced that they will report first half, 2026 results on May 13, 2026 Reported Earnings • Feb 07
First quarter 2026 earnings released: EPS: JP¥38.68 (vs JP¥28.49 in 1Q 2025) First quarter 2026 results: EPS: JP¥38.68 (up from JP¥28.49 in 1Q 2025). Revenue: JP¥15.5b (down 8.0% from 1Q 2025). Net income: JP¥1.32b (up 36% from 1Q 2025). Profit margin: 8.5% (up from 5.8% in 1Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Announcement • Dec 10
Noevir Holdings Co., Ltd. to Report Q1, 2026 Results on Feb 05, 2026 Noevir Holdings Co., Ltd. announced that they will report Q1, 2026 results on Feb 05, 2026 Reported Earnings • Nov 08
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: JP¥235 (up from JP¥233 in FY 2024). Revenue: JP¥64.7b (up 1.4% from FY 2024). Net income: JP¥8.03b (flat on FY 2024). Profit margin: 12% (in line with FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.3%. Revenue is forecast to grow 1.9% p.a. on average during the next 2 years, compared to a 3.6% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Announcement • Nov 07
Noevir Holdings Co., Ltd., Annual General Meeting, Dec 09, 2025 Noevir Holdings Co., Ltd., Annual General Meeting, Dec 09, 2025. Announcement • Sep 26
Noevir Holdings Co., Ltd. to Report Fiscal Year 2025 Results on Nov 07, 2025 Noevir Holdings Co., Ltd. announced that they will report fiscal year 2025 results on Nov 07, 2025 Reported Earnings • Aug 06
Third quarter 2025 earnings released: EPS: JP¥43.39 (vs JP¥55.42 in 3Q 2024) Third quarter 2025 results: EPS: JP¥43.39 (down from JP¥55.42 in 3Q 2024). Revenue: JP¥15.2b (down 8.2% from 3Q 2024). Net income: JP¥1.48b (down 22% from 3Q 2024). Profit margin: 9.7% (down from 11% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Announcement • Jun 27
Noevir Holdings Co., Ltd. to Report Q3, 2025 Results on Aug 05, 2025 Noevir Holdings Co., Ltd. announced that they will report Q3, 2025 results on Aug 05, 2025 Declared Dividend • May 10
Dividend of JP¥225 announced Shareholders will receive a dividend of JP¥225. Ex-date: 29th September 2025 Payment date: 10th December 2025 Dividend yield will be 5.3%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not adequately covered by earnings (96% earnings payout ratio) nor is it covered by cash flows (172% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 6.6% to bring the payout ratio under control. EPS is expected to grow by 5.7% over the next 3 years, which should be enough to bring the dividend into a sustainable range. Reported Earnings • May 09
Second quarter 2025 earnings released: EPS: JP¥48.83 (vs JP¥46.58 in 2Q 2024) Second quarter 2025 results: EPS: JP¥48.83 (up from JP¥46.58 in 2Q 2024). Revenue: JP¥15.2b (up 1.5% from 2Q 2024). Net income: JP¥1.67b (up 4.8% from 2Q 2024). Profit margin: 11% (in line with 2Q 2024). Revenue is forecast to grow 1.9% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Announcement • Apr 01
Noevir Holdings Co., Ltd. to Report Q2, 2025 Results on May 08, 2025 Noevir Holdings Co., Ltd. announced that they will report Q2, 2025 results on May 08, 2025 Announcement • Mar 24
Noevir Holdings Co., Ltd.(TSE:4928) dropped from FTSE All-World Index (USD) Noevir Holdings Co., Ltd.(TSE:4928) dropped from FTSE All-World Index (USD) Price Target Changed • Feb 07
Price target decreased by 11% to JP¥4,530 Down from JP¥5,100, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of JP¥4,315. Stock is down 17% over the past year. The company is forecast to post earnings per share of JP¥233 for next year compared to JP¥233 last year. Reported Earnings • Feb 06
First quarter 2025 earnings released: EPS: JP¥28.49 (vs JP¥29.45 in 1Q 2024) First quarter 2025 results: EPS: JP¥28.49 (down from JP¥29.45 in 1Q 2024). Revenue: JP¥16.8b (up 1.1% from 1Q 2024). Net income: JP¥973.0m (down 3.3% from 1Q 2024). Profit margin: 5.8% (down from 6.1% in 1Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Announcement • Dec 03
Noevir Holdings Co., Ltd. to Report Q1, 2025 Results on Feb 05, 2025 Noevir Holdings Co., Ltd. announced that they will report Q1, 2025 results on Feb 05, 2025 Reported Earnings • Nov 09
Full year 2024 earnings: Revenues and EPS in line with analyst expectations Full year 2024 results: EPS: JP¥233 (up from JP¥225 in FY 2023). Revenue: JP¥63.8b (up 2.0% from FY 2023). Net income: JP¥7.97b (up 3.9% from FY 2023). Profit margin: 13% (in line with FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Announcement • Nov 08
Noevir Holdings Co., Ltd., Annual General Meeting, Dec 09, 2024 Noevir Holdings Co., Ltd., Annual General Meeting, Dec 09, 2024. Price Target Changed • Oct 04
Price target decreased by 7.2% to JP¥5,320 Down from JP¥5,730, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of JP¥5,200. Stock is down 1.7% over the past year. The company is forecast to post earnings per share of JP¥234 for next year compared to JP¥225 last year. Upcoming Dividend • Sep 20
Upcoming dividend of JP¥220 per share Eligible shareholders must have bought the stock before 27 September 2024. Payment date: 11 December 2024. The company is paying out more than 100% of its profits and is paying out 91% of its cash flow. Trailing yield: 4.1%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.0%). Reported Earnings • Aug 09
Third quarter 2024 earnings released: EPS: JP¥55.42 (vs JP¥59.23 in 3Q 2023) Third quarter 2024 results: EPS: JP¥55.42 (down from JP¥59.23 in 3Q 2023). Revenue: JP¥16.6b (up 3.9% from 3Q 2023). Net income: JP¥1.89b (down 6.4% from 3Q 2023). Profit margin: 11% (down from 13% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Reported Earnings • May 11
Second quarter 2024 earnings released: EPS: JP¥46.58 (vs JP¥43.68 in 2Q 2023) Second quarter 2024 results: EPS: JP¥46.58 (up from JP¥43.68 in 2Q 2023). Revenue: JP¥15.0b (up 2.2% from 2Q 2023). Net income: JP¥1.59b (up 6.6% from 2Q 2023). Profit margin: 11% (in line with 2Q 2023). Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Declared Dividend • May 11
Dividend of JP¥220 announced Dividend of JP¥220 is the same as last year. Ex-date: 27th September 2024 Payment date: 11th December 2024 Dividend yield will be 4.2%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not adequately covered by earnings (99% earnings payout ratio) nor is it adequately covered by cash flows (92% cash payout ratio). The dividend has increased by an average of 19% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 9.9% to bring the payout ratio under control. EPS is expected to grow by 12% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Announcement • May 10
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024 Noevir Holdings Co., Ltd. provided dividend guidance for the fiscal year ending September 30, 2024. For the year, the company expects to pay dividend of JPY 220.00 per share against JPY 220.00 per share paid a year ago. Announcement • Mar 03
Noevir Holdings Co., Ltd. to Report Q2, 2024 Results on May 09, 2024 Noevir Holdings Co., Ltd. announced that they will report Q2, 2024 results on May 09, 2024 Reported Earnings • Feb 10
First quarter 2024 earnings released: EPS: JP¥29.45 (vs JP¥34.55 in 1Q 2023) First quarter 2024 results: EPS: JP¥29.45 (down from JP¥34.55 in 1Q 2023). Revenue: JP¥16.6b (up 2.5% from 1Q 2023). Net income: JP¥1.01b (down 15% from 1Q 2023). Profit margin: 6.1% (down from 7.3% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Announcement • Dec 03
Noevir Holdings Co., Ltd. to Report Q1, 2024 Results on Feb 08, 2024 Noevir Holdings Co., Ltd. announced that they will report Q1, 2024 results on Feb 08, 2024 Reported Earnings • Nov 08
Full year 2023 earnings: EPS misses analyst expectations Full year 2023 results: EPS: JP¥225 (up from JP¥222 in FY 2022). Revenue: JP¥62.6b (up 2.3% from FY 2022). Net income: JP¥7.67b (up 1.1% from FY 2022). Profit margin: 12% (in line with FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.2%. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Announcement • Nov 07
Noevir Holdings Co., Ltd., Annual General Meeting, Dec 08, 2023 Noevir Holdings Co., Ltd., Annual General Meeting, Dec 08, 2023. Upcoming Dividend • Sep 21
Upcoming dividend of JP¥215 per share at 3.8% yield Eligible shareholders must have bought the stock before 28 September 2023. Payment date: 11 December 2023. Payout ratio is on the higher end at 96%, and the cash payout ratio is above 100%. Trailing yield: 3.8%. Within top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.7%). Announcement • Sep 08
Noevir Holdings Co., Ltd. to Report Fiscal Year 2023 Results on Nov 07, 2023 Noevir Holdings Co., Ltd. announced that they will report fiscal year 2023 results on Nov 07, 2023 Reported Earnings • Aug 08
Third quarter 2023 earnings released: EPS: JP¥59.23 (vs JP¥48.92 in 3Q 2022) Third quarter 2023 results: EPS: JP¥59.23 (up from JP¥48.92 in 3Q 2022). Revenue: JP¥16.0b (up 1.6% from 3Q 2022). Net income: JP¥2.02b (up 21% from 3Q 2022). Profit margin: 13% (up from 11% in 3Q 2022). Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Announcement • May 28
Noevir Holdings Co., Ltd. to Report Q3, 2023 Results on Aug 07, 2023 Noevir Holdings Co., Ltd. announced that they will report Q3, 2023 results on Aug 07, 2023 Reported Earnings • May 12
Second quarter 2023 earnings released: EPS: JP¥43.68 (vs JP¥62.24 in 2Q 2022) Second quarter 2023 results: EPS: JP¥43.68 (down from JP¥62.24 in 2Q 2022). Revenue: JP¥14.7b (flat on 2Q 2022). Net income: JP¥1.49b (down 30% from 2Q 2022). Profit margin: 10% (down from 15% in 2Q 2022). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Reported Earnings • Feb 12
First quarter 2023 earnings released: EPS: JP¥34.55 (vs JP¥25.06 in 1Q 2022) First quarter 2023 results: EPS: JP¥34.55 (up from JP¥25.06 in 1Q 2022). Revenue: JP¥16.2b (up 4.1% from 1Q 2022). Net income: JP¥1.18b (up 38% from 1Q 2022). Profit margin: 7.3% (up from 5.5% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. Board Change • Jan 01
High number of new directors Audit & Supervisory Board Member Takashi Oyama was the last director to join the board, commencing their role in 2022. Announcement • Dec 04
Noevir Holdings Co., Ltd. to Report Q1, 2023 Results on Feb 07, 2023 Noevir Holdings Co., Ltd. announced that they will report Q1, 2023 results on Feb 07, 2023 Reported Earnings • Nov 16
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: JP¥222 (up from JP¥187 in FY 2021). Revenue: JP¥61.1b (up 19% from FY 2021). Net income: JP¥7.59b (up 19% from FY 2021). Profit margin: 12% (in line with FY 2021). Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 8.4%. Revenue is forecast to grow 1.9% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has fallen by 2% per year. Announcement • Nov 12
Noevir Holdings Co., Ltd., Annual General Meeting, Dec 08, 2022 Noevir Holdings Co., Ltd., Annual General Meeting, Dec 08, 2022. Reported Earnings • Nov 12
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: JP¥222 (up from JP¥187 in FY 2021). Revenue: JP¥61.1b (up 19% from FY 2021). Net income: JP¥7.59b (up 19% from FY 2021). Profit margin: 12% (in line with FY 2021). Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) also surpassed analyst estimates by 8.4%. Revenue is forecast to grow 1.9% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Personal Products industry in Japan. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings. Upcoming Dividend • Sep 22
Upcoming dividend of JP¥210 per share Eligible shareholders must have bought the stock before 29 September 2022. Payment date: 07 December 2022. Payout ratio is on the higher end at 96%, and the cash payout ratio is above 100%. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.7%). Announcement • Sep 03
Noevir Holdings Co., Ltd. to Report Fiscal Year 2022 Results on Nov 10, 2022 Noevir Holdings Co., Ltd. announced that they will report fiscal year 2022 results on Nov 10, 2022 Price Target Changed • Aug 08
Price target increased to JP¥6,070 Up from JP¥5,380, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of JP¥5,920. Stock is up 2.8% over the past year. The company is forecast to post earnings per share of JP¥205 for next year compared to JP¥187 last year. Reported Earnings • Aug 05
Third quarter 2022 earnings released: EPS: JP¥48.92 (vs JP¥46.76 in 3Q 2021) Third quarter 2022 results: EPS: JP¥48.92 (up from JP¥46.76 in 3Q 2021). Revenue: JP¥15.7b (up 21% from 3Q 2021). Net income: JP¥1.67b (up 4.6% from 3Q 2021). Profit margin: 11% (down from 12% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.7%, compared to a 3.9% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Announcement • Jun 03
Noevir Holdings Co., Ltd. to Report Q3, 2022 Results on Aug 04, 2022 Noevir Holdings Co., Ltd. announced that they will report Q3, 2022 results on Aug 04, 2022 Reported Earnings • May 13
Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint Second quarter 2022 results: EPS: JP¥62.24 (up from JP¥26.85 in 2Q 2021). Revenue: JP¥14.6b (up 22% from 2Q 2021). Net income: JP¥2.13b (up 132% from 2Q 2021). Profit margin: 15% (up from 7.6% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) were mostly in line with analyst estimates. Over the next year, revenue is forecast to grow 7.1%, compared to a 4.3% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Price Target Changed • Apr 27
Price target decreased to JP¥5,380 Down from JP¥5,800, the current price target is provided by 1 analyst. New target price is 8.5% above last closing price of JP¥4,960. Stock is up 3.5% over the past year. The company is forecast to post earnings per share of JP¥191 for next year compared to JP¥187 last year. Announcement • Apr 05
Noevir Holdings Co., Ltd. to Report First Half, 2022 Results on May 11, 2022 Noevir Holdings Co., Ltd. announced that they will report first half, 2022 results on May 11, 2022 Price Target Changed • Feb 10
Price target decreased to JP¥5,380 Down from JP¥5,800, the current price target is provided by 1 analyst. New target price is approximately in line with last closing price of JP¥5,140. Stock is up 2.6% over the past year. The company is forecast to post earnings per share of JP¥191 for next year compared to JP¥187 last year. Reported Earnings • Feb 09
First quarter 2022 earnings: EPS in line with expectations, revenues disappoint First quarter 2022 results: EPS: JP¥25.06 (down from JP¥31.82 in 1Q 2021). Revenue: JP¥15.6b (up 12% from 1Q 2021). Net income: JP¥856.0m (down 21% from 1Q 2021). Profit margin: 5.5% (down from 7.8% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) were mostly in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 4.9% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Board Change • Jan 02
High number of new directors Independent Outside Director Ryo Tsuchida was the last director to join the board, commencing their role in 2021. Reported Earnings • Nov 10
Full year 2021 earnings released: EPS JP¥187 (vs JP¥164 in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥51.3b (down 1.1% from FY 2020). Net income: JP¥6.38b (up 14% from FY 2020). Profit margin: 12% (up from 11% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Upcoming Dividend • Sep 22
Upcoming dividend of JP¥205 per share Eligible shareholders must have bought the stock before 29 September 2021. Payment date: 07 December 2021. Trailing yield: 3.5%. Within top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (1.4%). Reported Earnings • Aug 04
Third quarter 2021 earnings released: EPS JP¥46.76 (vs JP¥34.52 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥13.0b (up 8.7% from 3Q 2020). Net income: JP¥1.60b (up 36% from 3Q 2020). Profit margin: 12% (up from 9.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Reported Earnings • May 03
Second quarter 2021 earnings released: EPS JP¥26.85 (vs JP¥30.45 in 2Q 2020) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: JP¥12.0b (down 2.7% from 2Q 2020). Net income: JP¥917.0m (down 12% from 2Q 2020). Profit margin: 7.6% (down from 8.4% in 2Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 15% per year. Is New 90 Day High Low • Mar 09
New 90-day high: JP¥5,130 The company is up 20% from its price of JP¥4,275 on 09 December 2020. The Japanese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Personal Products industry, which is up 1.0% over the same period. Announcement • Mar 04
Noevir Holdings Co., Ltd. to Report Q2, 2021 Results on Apr 30, 2021 Noevir Holdings Co., Ltd. announced that they will report Q2, 2021 results on Apr 30, 2021 Reported Earnings • Feb 03
First quarter 2021 earnings released: EPS JP¥31.82 (vs JP¥39.76 in 1Q 2020) The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2021 results: Revenue: JP¥13.9b (down 10% from 1Q 2020). Net income: JP¥1.09b (down 20% from 1Q 2020). Profit margin: 7.8% (down from 8.8% in 1Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 14% per year. Is New 90 Day High Low • Feb 01
New 90-day high: JP¥4,880 The company is up 4.0% from its price of JP¥4,695 on 02 November 2020. The Japanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 6.0% over the same period. Is New 90 Day High Low • Dec 03
New 90-day low: JP¥4,290 The company is down 13% from its price of JP¥4,935 on 04 September 2020. The Japanese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 9.0% over the same period. Price Target Changed • Dec 01
Price target raised to JP¥4,890 Up from JP¥4,350, the current price target is provided by 1 analyst. The new target price is 13% above the current share price of JP¥4,335. As of last close, the stock is down 31% over the past year. Announcement • Nov 07
Noevir Holdings Co., Ltd., Annual General Meeting, Dec 04, 2020 Noevir Holdings Co., Ltd., Annual General Meeting, Dec 04, 2020. Announcement • Sep 04
Noevir Holdings Co., Ltd. to Report Fiscal Year 2020 Results on Nov 05, 2020 Noevir Holdings Co., Ltd. announced that they will report fiscal year 2020 results on Nov 05, 2020 Announcement • Aug 06
An unknown buyer acquired a 12.9% stake in Noevir Holdings Co., Ltd. (TSE:4928) from Takashi Okura. An unknown buyer acquired a 12.9% stake in Noevir Holdings Co., Ltd. (TSE:4928) from Takashi Okura on August 3, 2020. As part of the transaction, Takashi Okura sold 4,410,000 shares in Noevir Holdings Co., Ltd. Post completion, Takashi Okura holds 2.93% stake in Noevir Holdings Co., Ltd.
An unknown buyer completed the acquisition of a 12.9% stake in Noevir Holdings Co., Ltd. (TSE:4928) from Takashi Okura on August 3, 2020. 
